Omslagsbillede

Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis.

Cutaneous leishmaniasis (LC) is a complex and variable disease in terms of epidemiology, aetiology, pathology and clinical characteristics. The mainstay of treatment is still pentavalent antimony (Sbv) compounds administered systemically, despite their recognized toxicity. The advantages of antimony...

Fuld beskrivelse

Saved in:

Bibliografiske detaljer
Main Authors:	Nayara C Brito (Author), Tália S Machado de Assis (Author), Ana Rabello (Author), Gláucia Cota (Author)
Format:	Bog
Udgivet:	Public Library of Science (PLoS), 2019-12-01T00:00:00Z.
Fag:	article
Online adgang:	Connect to this object online.
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Lignende værker

Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis
af: Michal Solomon, et al.
Udgivet: (2024)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
af: Deninson Alejandro Vargas, et al.
Udgivet: (2019)

Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.
af: Brandon A Berger, et al.
Udgivet: (2017)

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial.
af: Jamile Lago, et al.
Udgivet: (2023)

Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial
af: Jamile Lago, et al.
Udgivet: (2023)

Correction: Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial.
af: Jamile Lago, et al.
Udgivet: (2023)

Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
af: Mohamad Javad Yazdanpanah, et al.
Udgivet: (2011)

An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil.
af: Carla Oliveira-Ribeiro, et al.
Udgivet: (2021)

Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate.
af: Jairo E Perez-Franco, et al.
Udgivet: (2016)

Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran.
af: Mohammad Reza Aflatoonian, et al.
Udgivet: (2019)

Natural resistance to meglumine antimoniate is associated with treatment failure in cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis.
af: Olga Lucía Fernández, et al.
Udgivet: (2024)

Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis
af: Diana Berenguer, et al.
Udgivet: (2019)

Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.
af: Maria Del Mar Castro, et al.
Udgivet: (2017)

First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report
af: Omid MOZAFARI, et al.
Udgivet: (2016)

Intralesional 8.33% Rifamycin infiltration; New treatment for cutaneous leishmaniasis
af: Nameer K. Al-Sudany, et al.
Udgivet: (2016)

"Cheaper and better": Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia.
af: Daniel Eid Rodríguez, et al.
Udgivet: (2019)

Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario.
af: Mariana Lourenço Freire, et al.
Udgivet: (2020)

Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial.
af: Amir Javadi, et al.
Udgivet: (2022)

Risk factors for antimony treatment failure in American Cutaneous Leishmaniasis in Northwestern-Argentina.
af: María F García-Bustos, et al.
Udgivet: (2021)

Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis
af: Vahid Mashayekhi Goyonlo, et al.
Udgivet: (2014)

Economic impact of localized cutaneous leishmaniasis on adult patients of a referral service in Belo Horizonte, Minas Gerais State, Brazil
af: Endi Lanza Galvão, et al.
Udgivet: (2020)

Leishmaniose cutânea com desfecho fatal durante tratamento com antimonial pentavalente American cutaneous leishmaniasis with fatal outcome during pentavalent antimoniate treatment
af: Meiri Vanderlei Nogueira de Lima, et al.
Udgivet: (2007)

The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial.
af: Masoumeh Tayyebi, et al.
Udgivet: (2021)

The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy.
af: Ines Lakhal-Naouar, et al.
Udgivet: (2015)

Evaluation of Correlation between the in Vitro Susceptibility of Field Isolates of Leishmania major and Clinical Outcomes of Meglumine Antimoniate Therapy in Fars Province, Iran
af: Nafiseh Ghobakhloo, et al.
Udgivet: (2017)

Cost-effectiveness study of therapeutic approaches for mucosal leishmaniasis
af: Janaína de Pina Carvalho, et al.
Udgivet: (2024)

Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review
af: Taisa Rocha Navasconi Berbert, et al.
Udgivet: (2018)

Cellular infiltrate in cutaneous leishmaniasis lesions and therapeutic outcome,
af: Camila Sampaio Ribeiro, et al.
Udgivet: (2021)

Budgetary impact of diagnostic tests for visceral leishmaniasis in Brazil
af: Tália Santana Machado de Assis, et al.
Udgivet: (2017)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B.
af: Gloria Morizot, et al.
Udgivet: (2016)

Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis
af: Moradi Shahram, et al.
Udgivet: (2007)

First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.
af: Cesar Miranda-Verastegui, et al.
Udgivet: (2009)

Effect of intralesional sodium stibogluconate alone versus combinations with topical trichloroacetic acid 50% or fractional carbon dioxide laser on cutaneous leishmaniasis
af: Shaimaa M Ali, et al.
Udgivet: (2023)

Estudo clínico randomizado comparando antimoniato de meglumina, pentamidina e anfotericina B para o tratamento da leishmaniose cutânea ocasionada por Leishmania guyanensis A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis
af: Leandro Ourives Neves, et al.
Udgivet: (2011)

Nail psoriasis treated with intralesional methotrexate infiltration
af: Artur Antônio Duarte, et al.
Udgivet: (2019)

Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions.
af: Cristian Valencia, et al.
Udgivet: (2012)

Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis
af: Masoud Maleki, et al.
Udgivet: (2012)

Acute erythroid toxicity in visceral leishmaniasis: A rare complication of antimonial therapy
af: Sharma Sunita, et al.
Udgivet: (2008)

Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis.
af: Mariana Lourenço Freire, et al.
Udgivet: (2019)

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
af: Guilherme S. Ramos, et al.
Udgivet: (2022)